MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $6.9 million in its third quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 37 cents.
The medical device company focused on psychiatric disorders posted revenue of $16 million in the period.
For the current quarter ending in December, Neuronetics said it expects revenue in the range of $16.7 million to $17.7 million.
The company expects full-year revenue in the range of $62 million to $63 million.
Neuronetics shares have decreased 54% since the beginning of the year. The stock has fallen 64% in the last 12 months.